Cantel Medical Corp. (CMN) Tops Q4 EPS by 3c

Cantel Medical Corp. (NYSE: CMN) reported Q4 EPS of $0.35, $0.03 better than the analyst estimate of $0.32. Revenue for the quarter came in at $98.7 million versus the consensus estimate of $102.7 million.

For earnings history and earnings-related data on Cantel Medical Corp. (CMN) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• zSpace, Inc. (ZSPC) Reports Q2 results